II. Causes: Acute Severe Pain Out of Proportion to Clinical Findings
- Gastrointestinal or Genitourinary
- Acute Painful Syncope
- Musculoskeletal
- Miscellaneous Disorders
- Acute Angle-Closure Glaucoma
- Sickle Cell Crisis
- Early Shingles (first 72 hours before rash development)
III. Management: Acute Pain
- Treat new acute, painful conditions regardless of Opiate history while patient is in the emergency department
- Examples: Long bone Fractures, Appendicitis, Renal Colic, Acute Cholecystitis
- Rapid control of acute symptoms in the emergency department
- Pain is considered an emergency condition by EMTALA
- Set reasonable expectations for Acute Pain Management (improved but not 100% resolved)
- Paranteral Opioid approach (if indicated)
- Control pain early with serial doses of Opioids and frequent reassessment
- Early definitive control of pain breaks the pain cycle
- Avoid under-treating with small, ineffective doses
- Consider Non-Opioid Analgesics and other measures
- See Below
- Use stepped approach to home Acute Pain Management
- See Acute Pain Stepped Oral Analgesics as below
- Gear Oral Analgesic starting point based on response to acute Pain Medications in ED
- Use Acetaminophen and NSAIDs in combination (if not contraindicated)
- Common approach
- Acetaminophen 1000 mg orally every 6 hours AND
- Ibuprofen 400 to 600 mg orally every 6 to 8 hours
- Study used Ibuprofen 200 mg with Acetaminophen 500 mg
- Very effective for post-operative pain without the risks of Opioids
- Derry (2013) Cochrane Database Syst Rev (6):CD010210 +PMID:23794268 [PubMed]
- Common approach
- Consider adjunctive topical agents
- Diclofenac Gel
- Lidocaine Patch (4% patch is OTC and typically <$10 for 5 patches as of 2018)
- TENS unit
- Avoid Tramadol
- Equivalent to Non-Opioid Analgesics (but with increased Drug Interactions)
- Opioid management
- The best prevention of Opioid Abuse is in keeping Opioid naive patients, Opioid naive
- Prescribe a short course for 2-3 days of acute pain to allow for follow-up and re-evaluation (e.g. 8 tablets)
- Encourage to use other non-Opioid agents first, and limit Opioids to pain interfering with sleep
- Consider Morphine immediate release for adults moderate to severe pain
- Morphine IR 15 mg PO is equivalent to 5 mg IV
- Start with 7.5 mg orally every 4-6 hours as needed
- Morphine is less euphoric than Oxycodone and Hydrocodone
- Employ non-pharmacologic measures
- See Musculoskeletal Injury Management (e.g. RICE-M, Contrast Baths)
- Reduce provocative activities (e.g. crutch walking, work limitations)
- Avoid inactivity and maintain range of motion
- Consider physical therapy
- Short outpatient course of Acute Pain Management
- References
- (2015) Presc Lett 22(4)
- Birnbaumer (2013) Analgesia and Procedural Sedation, EM Bootcamp, CEME Lecture
IV. Management: Acute Pain Stepped Oral Analgesics
- See Pediatric Analgesics
- Step 1: Acetaminophen with or without Ibuprofen
- Acetaminophen 1000 mg orally every 6 hours
- Considered best first-line Oral Analgesic
- Safe and effective for most mild to moderate pain
- Does not have antiinflammatory activity
- Ibuprofen 400 to 600 mg orally every 6 hours
- GI safety similar to Placebo up to 1200 mg/day
- More effective in Dental Pain and Dysmenorrhea
- Antiinflammatory activity starts at 600 mg doses
- Acetaminophen 1000 mg orally every 6 hours
- Step 2
- Step 3
- Consider adjunctive topical agents (e.g. Diclofenac Gel, Lidoderm patch or TENS unit)
- Step 4
- Morphine IR 7.5 mg (one half of 15 mg tablet) orally every 4-6 hours
- Consider Morphine instead of Oxycodone or Hydrocodone (Morphine is less euphoric)
- Oxycodone (Roxicodone) 5 mg every 4-6 hours or
- Combination Agents
- Non-combination agents (Morphine or Oxycodone) are preferred
- Non-combination agents allow for continued scheduled NSAID and Tylenol
- Opioid is only taken if there is break through pain (e.g. night pain)
- Combination agents risk dosing complexity and Acetaminophen Overdose
- Oxycodone with Acetaminophen (Percocet)
- Hydrocodone-Acetaminophen (Vicodin) 5/325 to 10/650 every 6 hours prn
- Non-combination agents (Morphine or Oxycodone) are preferred
- Morphine IR 7.5 mg (one half of 15 mg tablet) orally every 4-6 hours
- Step 5
- Consider Topical Analgesic (see step 3 above)
- Consider Systemic adjunctive medications if pain persists
- See Chronic Pain Management
- Tricyclic Antidepressants (e.g. Amitriptyline)
- Anticonvulsants (e.g. Gabapentin)
- Avoid Analgesics with poor efficacy and increased adverse effect risks
- Codeine (e.g. Tylenol #3)
- Propoxyphene (Darvon, Darvocet)
- Tramadol (Ultram)
V. Management: Acute pain Non-Opioid ParenteralAnalgesics
- Typical ParenteralAnalgesics
- Ketorolac (Toradol) 10-15 mg IV
- Acetaminophen 1000 mg oral or IV (over 15 min)
- Novel Acute Pain Management strategies (use with caution only)
- Obtain Informed Consent and review dosing, adverse effects and risks prior to use
- Ketamine 0.2 mg/kg IV over 10 min, then 0.15 mg/kg/hour
- Lidocaine 2% at 1.5 to 2.5 mg/kg/h IV for 2-4 hours
- Clonidine 0.3 to 2 mcg/kg/h IV infusion
- Dexemedetomidine 0.2 to 0.3 mcg/kg/h IV infusion
-
Acute Abdominal Pain
- Ketorolac (esp. for suspected Renal Colic)
- Ketamine (see above)
- Acute Headache
- IV crystalloid hydration (NS, LR) AND
- Ketorolac AND
- Diphenhydramine AND
- Prochlorperazine, Metoclopramide or Olanzapine
- Non-radicular back pain
- Acute neuropathic pain or back pain
- Gabapentin (Neurontin) 300 mg orally
- Corticosteroid (Prednisone or Methylprednisolone)
- Typical and novel approaches as above
- Regional pain management
- References
- Hipskind and Kamboj (2016) Crit Dec Emerg Med 30(10): 15-23
VI. Evaluation: Determine if presenting complaint is an exacerbation of Chronic Pain
- Review medical record
- Medication refills (especially Opioids)
- Clinic and emergency department visits for painful conditions
- Review Prescription Drug Monitoring Programs (alliance of states sites)
- Determine if patient is in a pain program
- Review Controlled Substance Agreement
- Communicate with primary pain provider if available
- Alternatively, notify them that patient was seen for pain in Emergency Department
- Ask about Chemical Dependency and prescribed medication misuse
- Drug Diversion
- Chemical Dependency
- Recreational use of prescription medications
- History of prescription drug Overdose
- Be respectful
- Assess patients appropriately without immediately stereotyping or discounting their presenting symptoms
- Articulate to the patient what is doable for pain management (e.g. 30% reduction in pain, such as 6/10 to a 3-4/10)
- Discuss follow-up, alternatives and expectations
- Direct patients to follow-up within 1 week with primary care or pain management
- Patient should consider neuropathic Pain Medications (e.g. Gabapentin, Tricyclic Antidepressants, Duloxetine)
- Avoid Opioid doses above 50 mg/day Morphine Equivalents for non-cancer Chronic Pain
- Opioid doses >90 mg/day Morphine Equivalents for non-cancer, non-Palliative Care is a red flag
- Function that does not improve 30% on Chronic Opioids should be weaned (slowly, 10% every 1-2 weeks)
- (2016) Presc Lett 23(5): 25
-
Informed Consent for Opioid Prescription
- See Opioid Prescription in Acute Pain
- Review goal of improved function (not complete pain elimination)
- Review short-term Opioid course
- Review risks of longterm tolerance, dependence and addiction with longer use
VII. Management: Exacerbation of Chronic Pain
- Consider establishing an emergency department care plan for Chronic Pain patients
- Does not replace an outpatient pain management program or primary care provider management
- Creates a consistent plan of pain management across a group of emergency providers
- Reviews specific patient resources, contacts, and precautions in treating the patient's pain
- Review flare management
- Patient not in pain program
- Discuss the problem with emergency department delivery of Chronic Pain Management
- Encourage close follow-up with primary care
- Encourage establishing with a pain management program
- Review that pain programs exist with better longterm outcomes
VIII. Resources
- Opioid Alternatives Chart (CERTA)
IX. References
- Hipskind and Kamboj (2016) Crit Dec Emerg Med 30(10): 15-23
- Jaben in Herbert (2012) EM: Rap 12(9): 8